Tuesday 15 December, 14:00 – 16:30
Programme
Pharmacology in the time of COVID
| 14:00 | Introduction and welcome | Dr Tim Hardman, Chairman, AHPPI |
| 14:10 | Burden of therapy: a novel safety assessment | Dr Ayad Abdulahad, BOTh Analytics |
| 14.40 |
How we have contained Covid-19 in a dedicated clinical trials unit. |
Dr Jorg Taubel, Richmond Pharmacology |
| 15.10 | Summary of MHRA preparations for BREXIT | Dr Kirsty Wydenbach, Clinical Trials Unit, MHRA |
| 15.55 | Partnering with the U.K. to investigate, and supply on compassionate grounds, an investigational medicine for COVID-19 in wave 1 of the pandemic. | Dr Philip Troke, Gilead Sciences Ltd. |
| 16:25 | Running phase 1 clinical trials during a pandemic | Radboud van Trigt and Jan Leendert Pouwel Brouwer, PRA Health Sciences |
| 16.50 | Discussion and closing remarks | Dr Tim Hardman, Chairman, AHPPI |
CPD points for this meeting have been applied for.
Please contact us with any questions at info@ahppi.org.uk
We are open for sponsorship for this year’s meeting.